Framed as a research schedule (not a prescription): Activation (Weeks 12): Begin at the documented once-daily dose and hold it steady
"I was gambling my health, my family and, in many respects, my life." More reporting by Ruth Clegg Published29 March

Research Verdict: When to Use Each or Both Choose BPC-157 When Research Focuses On: Gastrointestinal healing and protection Tendon and ligament injuries Nerve regeneration and neuroprotection Situations requiring oral administration Protection from NSAID or other toxic damage Choose TB-500 When Research Focuses On: Cardiac tissue repair and cardioprotection Wound healing and scar reduction Systemic anti-inflammatory effects Muscle regeneration Hair follicle research Consider Combination When: Comprehensive tissue repair is the goal (e.g., complex injury involving multiple tissue types) Maximizing angiogenesis AND cell migration is desired Research hypothesis involves sequential healing phases Mechanistic Rationale for Stacking: The combination addresses different phases of healingBPC-157 promotes blood vessel ingrowth and initial cytoprotection, while TB-500 facilitates the cellular repair and remodeling that follows vascularization

When taken orally, GHK-Cu is believed to have potential health benefits, including promoting tissue repair, enhancing wound healing, supporting immune function, and improving skin health by stimulating collagen production
She adds that starting with a lower dose of 2 mg/week instead of 4 mg/week may help mitigate adverse effects